Advanced penile cancer with iliac lymph node involvement treated with radiation and concurrent gemcitabine

Abstract : Penile cancer is a rare entity with only 2000 new cases a year in the United States. Even though early stage penile cancer has an excellent prognosis, patients with positive pelvic lymph nodes have an overall 5-year survival rate under 10%. There is no consensus for the management of pelvic node-positive patients, although most guidelines are in favour of pelvic lymph node dissection for patients with two or more positive nodes, followed by adjuvant chemotherapy. We describe here the case of a patient with numerous metastatic lymph nodes at diagnosis, treated with chemoradiation (66Gy with concurrent gemcitabine) after failure of first-line chemotherapy and still alive and disease-free 7 years after diagnosis.
Type de document :
Article dans une revue
Liste complète des métadonnées

https://hal.umontpellier.fr/hal-02278858
Contributeur : Nathalie Salvy-Cordoba <>
Soumis le : mercredi 4 septembre 2019 - 16:43:18
Dernière modification le : mercredi 20 novembre 2019 - 03:18:26

Identifiants

Citation

A. Lapierre, O. Riou, A. Flechon, N. Mottet, D. Azria. Advanced penile cancer with iliac lymph node involvement treated with radiation and concurrent gemcitabine. Cancer Radiothérapie, Elsevier Masson, 2017, 21 (2), pp.134-137. ⟨10.1016/j.canrad.2016.10.003⟩. ⟨hal-02278858⟩

Partager

Métriques

Consultations de la notice

19